Mechanisms of altered fatty acid and phospholipid levels in hyperhomocysteinemia

Angela M. Devlin, Tim J. Green

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Hyperhomocysteinemia (HHcy) is a risk factor for several health conditions including cardiovascular disease. Endothelial dysfunction is a key feature of HHcy but the underlying molecular mechanisms are not fully understood. Evidence has accumulated to support a role for alterations in lipid metabolism in the pathology of HHcy. Homocysteine is linked to lipid metabolism through the methionine cycle and the synthesis of phosphatidylcholine. Liver phosphatidylcholine is required for the synthesis and secretion of hepatic lipoproteins and therefore plays an indirect role in the delivery of fatty acids to the vascular endothelium and other extrahepatic tissues. In this review, we present current information on the affect of HHcy on phospholipid and fatty acid metabolism and speculate on the potential role this may play in the pathology of HHcy.

LanguageEnglish
Pages159-166
Number of pages8
JournalFuture Lipidology
Volume4
Issue number2
DOIs
Publication statusPublished - 2009

Keywords

  • Arachidonic acid
  • Docosahexaenoic acid
  • Fatty acid
  • Hyperhomocysteinemia
  • Liver
  • Methionine
  • Methylation
  • Mice
  • Phosphatidylcholine
  • Phosphatidylethanolamine

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine

Cite this

@article{a19744ab9af14a7a9a6b5035fb2e29f2,
title = "Mechanisms of altered fatty acid and phospholipid levels in hyperhomocysteinemia",
abstract = "Hyperhomocysteinemia (HHcy) is a risk factor for several health conditions including cardiovascular disease. Endothelial dysfunction is a key feature of HHcy but the underlying molecular mechanisms are not fully understood. Evidence has accumulated to support a role for alterations in lipid metabolism in the pathology of HHcy. Homocysteine is linked to lipid metabolism through the methionine cycle and the synthesis of phosphatidylcholine. Liver phosphatidylcholine is required for the synthesis and secretion of hepatic lipoproteins and therefore plays an indirect role in the delivery of fatty acids to the vascular endothelium and other extrahepatic tissues. In this review, we present current information on the affect of HHcy on phospholipid and fatty acid metabolism and speculate on the potential role this may play in the pathology of HHcy.",
keywords = "Arachidonic acid, Docosahexaenoic acid, Fatty acid, Hyperhomocysteinemia, Liver, Methionine, Methylation, Mice, Phosphatidylcholine, Phosphatidylethanolamine",
author = "Devlin, {Angela M.} and Green, {Tim J.}",
year = "2009",
doi = "10.2217/CLP.09.3",
language = "English",
volume = "4",
pages = "159--166",
journal = "Future Lipidology",
issn = "1746-0875",
publisher = "Future Medicine Ltd.",
number = "2",

}

Mechanisms of altered fatty acid and phospholipid levels in hyperhomocysteinemia. / Devlin, Angela M.; Green, Tim J.

In: Future Lipidology, Vol. 4, No. 2, 2009, p. 159-166.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Mechanisms of altered fatty acid and phospholipid levels in hyperhomocysteinemia

AU - Devlin, Angela M.

AU - Green, Tim J.

PY - 2009

Y1 - 2009

N2 - Hyperhomocysteinemia (HHcy) is a risk factor for several health conditions including cardiovascular disease. Endothelial dysfunction is a key feature of HHcy but the underlying molecular mechanisms are not fully understood. Evidence has accumulated to support a role for alterations in lipid metabolism in the pathology of HHcy. Homocysteine is linked to lipid metabolism through the methionine cycle and the synthesis of phosphatidylcholine. Liver phosphatidylcholine is required for the synthesis and secretion of hepatic lipoproteins and therefore plays an indirect role in the delivery of fatty acids to the vascular endothelium and other extrahepatic tissues. In this review, we present current information on the affect of HHcy on phospholipid and fatty acid metabolism and speculate on the potential role this may play in the pathology of HHcy.

AB - Hyperhomocysteinemia (HHcy) is a risk factor for several health conditions including cardiovascular disease. Endothelial dysfunction is a key feature of HHcy but the underlying molecular mechanisms are not fully understood. Evidence has accumulated to support a role for alterations in lipid metabolism in the pathology of HHcy. Homocysteine is linked to lipid metabolism through the methionine cycle and the synthesis of phosphatidylcholine. Liver phosphatidylcholine is required for the synthesis and secretion of hepatic lipoproteins and therefore plays an indirect role in the delivery of fatty acids to the vascular endothelium and other extrahepatic tissues. In this review, we present current information on the affect of HHcy on phospholipid and fatty acid metabolism and speculate on the potential role this may play in the pathology of HHcy.

KW - Arachidonic acid

KW - Docosahexaenoic acid

KW - Fatty acid

KW - Hyperhomocysteinemia

KW - Liver

KW - Methionine

KW - Methylation

KW - Mice

KW - Phosphatidylcholine

KW - Phosphatidylethanolamine

UR - http://www.scopus.com/inward/record.url?scp=67249093241&partnerID=8YFLogxK

U2 - 10.2217/CLP.09.3

DO - 10.2217/CLP.09.3

M3 - Review article

VL - 4

SP - 159

EP - 166

JO - Future Lipidology

T2 - Future Lipidology

JF - Future Lipidology

SN - 1746-0875

IS - 2

ER -